Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Decitabine MeSH Descriptor Data 2025


MeSH Heading
Decitabine
Tree Number(s)
D02.145.150.500
D03.383.742.680.245.217.500
D13.570.685.245.217.500
D13.570.800.286.300.500
Unique ID
D000077209
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077209
Scope Note
An azacitidine derivative and antineoplastic antimetabolite. It inhibits DNA methyltransferase to re-activate silent genes, limiting METASTASIS and NEOPLASM DRUG RESISTANCE. Decitabine is used in the treatment of MYELODISPLASTIC SYNDROMES, and ACUTE MYELOID LEUKEMIA.
Entry Term(s)
2'-Deoxy-5-azacytidine
5-Aza-2'-deoxycytidine
5-AzadC
5-Azadeoxycytidine
5-Deoxyazacytidine
5AzadC
AzadC Compound
Dacogen
Decitabine Mesylate
NSC 127716
NSC-127716
Pharm Action
Antimetabolites, Antineoplastic
Enzyme Inhibitors
Registry Numbers
776B62CQ27
0
6U3LPL9PRN
Related Numbers
2353-33-5
6U3LPL9PRN
See Also
Cytarabine
Public MeSH Note
2019; DECITABINE was indexed under AZACITIDINE 1981-2018, and under DEOXYCITIDNE 1977-1980
History Note
2019 (1977)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/07/02
Decitabine Preferred
NSC 127716 Narrower
Dacogen Narrower
Decitabine Mesylate Narrower
5-Deoxyazacytidine Related
page delivered in 0.128s